Cargando…
Circulating microRNAs as biomarkers for severe coronary artery disease
Coronary artery disease (CAD) is the second leading cause of death after stroke in China. Percutaneous coronary intervention (PCI) significantly improves the prognosis of CAD patients. This study aimed to evaluate the diagnostic value of circulating microRNAs (miRNAs) in patients with severe CAD req...
Autores principales: | Zhang, Xuelin, Cai, Haipeng, Zhu, Minqi, Qian, Yinfen, Lin, Shanan, Li, Xiaoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220532/ https://www.ncbi.nlm.nih.gov/pubmed/32332683 http://dx.doi.org/10.1097/MD.0000000000019971 |
Ejemplares similares
-
The relationship of MicroRNA-21 and plaque stability in acute coronary syndrome
por: He, Wangwei, et al.
Publicado: (2019) -
Circulating “LncPPARδ” From Monocytes as a Novel Biomarker for Coronary Artery Diseases
por: Cai, Yue, et al.
Publicado: (2016) -
Identification of microRNAs as diagnostic biomarkers for acute myocardial infarction in Asian populations: A systematic review and meta-analysis
por: Wang, Qian, et al.
Publicado: (2017) -
Prognostic value of microRNAs in heart failure: A meta-analysis
por: Yang, Jie, et al.
Publicado: (2021) -
Differential Expression of Hypertension-Associated MicroRNAs in the Plasma of Patients With White Coat Hypertension
por: Cengiz, Mahir, et al.
Publicado: (2015)